- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 28.01. | FDA accepts Otsuka's centanafadine application for ADHD treatment | ||
| 28.01. | Insilico and Qilu Pharmaceutical sign deal for cardiometabolic therapies | ||
| 27.01. | UK and certain European countries lose WHO's measles-free status | ||
| 27.01. | Mirum acquires Bluejay Therapeutics to expand rare liver disease pipeline | ||
| 27.01. | FDA to review Eisai's Leqembi Iqlik sBLA for Alzheimer's | ||
| 26.01. | Internet of Medical Things beats AI as top ranked growth driver among life science CEOs | ||
| 26.01. | UK biotechs suffered restricted financing in 2025 | ||
| 26.01. | MSD ends takeover talks with Revolution Medicines | ||
| 26.01. | NICE greenlights Pfizer's Talzenna for NHS use | ||
| 23.01. | Corxel raises $287m as obesity continues to spark investor interest | ||
| 23.01. | Daiichi Sankyo and AstraZeneca's Enhertu gains NMPA approval for HER2 GEJ | ||
| 22.01. | BMS bets on Janux's novel solid tumour therapy through $850m deal | ||
| 22.01. | US set to officially exit WHO in culmination of Trump's domestic push | ||
| 22.01. | Heart disease and stroke deaths take a downturn, AHA report reveals | ||
| 22.01. | Johnson & Johnson reports 9.1% increase in sales for Q4 2025 | ||
| 22.01. | Opna Bio's OPN-2853 secures FDA's orphan drug status for myelofibrosis | ||
| 21.01. | Davos26: Trump says tariff threats helped fix US drug pricing 'unfairness' | ||
| 21.01. | Pfizer and Novavax ink $530m vaccine delivery licensing deal | ||
| 21.01. | BMS and Microsoft partner for AI-based lung cancer detection | ||
| 21.01. | Novo Nordisk and Aspect Biosystems advance partnership for diabetes therapies | ||
| 20.01. | Shionogi expands ViiV Healthcare stake by $2.13bn as Pfizer sells up | ||
| 20.01. | GSK scoops up RAPT Therapeutics for $2.2bn | ||
| 20.01. | DeepHow introduces PharmaCloud for pharmaceutical manufacturers | ||
| 20.01. | iRegene receives FDA RMAT designation for NouvNeu001 to treat Parkinson's | ||
| 19.01. | UK's pharma outlook buoyed by trans-Atlantic trade policies |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.